In a report released on April 9, Nik Modi from RBC Capital maintained a Buy rating on Keurig Dr Pepper (KDP – Research Report), with a price target of $41.00. The company’s shares closed yesterday at $30.65.
Modi covers the Consumer Defensive sector, focusing on stocks such as Clorox, Colgate-Palmolive, and Constellation Brands. According to TipRanks, Modi has an average return of 6.5% and a 60.52% success rate on recommended stocks.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Keurig Dr Pepper with a $35.23 average price target, implying a 14.94% upside from current levels. In a report released on April 2, Bernstein also maintained a Buy rating on the stock with a $36.00 price target.
KDP market cap is currently $42.74B and has a P/E ratio of 20.02.
Based on the recent corporate insider activity of 63 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of KDP in relation to earlier this year. Last month, Robert S. Singer, a Director at KDP sold 14,132.00 shares for a total of $413,341.00.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Keurig Dr Pepper (KDP) Company Description:
Massachusetts-based Keurig Dr Pepper, Inc. operates as a non-alcoholic beverage company in the US and internationally. It operates through four segments: Coffee Systems, Packaged Beverages, Beverage Concentrates, and Latin America Beverages.
Read More on KDP:
- Keurig Dr Pepper price target lowered to $35 from $37 at Jefferies
- Keurig Dr Pepper call volume above normal and directionally bullish
- Keurig Dr Pepper backs FY24 adjusted EPS growth of high single digits
- Keurig Dr Pepper announces upcoming Keurig brewer and K-Cup pod offerings
- Keurig Dr Pepper price target lowered to $32 from $34 at Barclays
